UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

The Lancet (British edition), 2007-03, Vol.369 (9564), p.827-835

2007

Volltextzugriff (PDF)

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

The Lancet (British edition), 2002-07, Vol.360 (9327), p.109-113

2002

Volltextzugriff (PDF)

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

The New England journal of medicine, 2012-01, Vol.366 (1), p.9-19

2012

Volltextzugriff (PDF)

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9872), p.1107-1115

2013

Volltextzugriff (PDF)

Apixaban versus Warfarin in Patients with Atrial Fibrillation

The New England journal of medicine, 2011-09, Vol.365 (11), p.981-992

2011

Volltextzugriff (PDF)

Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with Non-ST-Segment-Elevation acute coronary syndrome : Results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial

Circulation (New York, N.Y.), 2007-10, Vol.116 (15), p.1647-1652

2007

Volltextzugriff (PDF)

Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51

Journal of the American College of Cardiology, 2013-07, Vol.62 (4), p.286-290

2013

Volltextzugriff (PDF)

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

The New England journal of medicine, 2005-09, Vol.353 (11), p.1095-1104

2005

Volltextzugriff (PDF)

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

The Lancet (British edition), 2004-08, Vol.364 (9435), p.675-684

2004

Volltextzugriff (PDF)

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial

The American heart journal, 2015-10, Vol.170 (4), p.683-694.e3

2015

Volltextzugriff (PDF)

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Journal of the American College of Cardiology, 2007-06, Vol.49 (23), p.2249-2255

2007

Volltextzugriff (PDF)

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Heart (British Cardiac Society), 2017-02, Vol.103 (4), p.293-299

2017

Volltextzugriff (PDF)

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

The American heart journal, 2019-07, Vol.213, p.35-46

2019

Volltextzugriff (PDF)

Who is ineligible for warfarin in atrial fibrillation?

The Lancet (British edition), 2009-08, Vol.374 (9689), p.510-511

Verheugt, Freek WA

2009

Volltextzugriff (PDF)

N-terminal pro–brain natriuretic peptide for additional risk stratification in patients with non–ST-elevation acute coronary syndrome and an elevated troponin T: An Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy

The American heart journal, 2007-04, Vol.153 (4), p.485-492

2007

Volltextzugriff (PDF)

An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial

The American heart journal, 2021-04, Vol.234, p.42-50

2021

Volltextzugriff (PDF)

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

Journal of the American College of Cardiology, 2002-08, Vol.40 (4), p.766-772

2002

Volltextzugriff (PDF)

Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized With Acute Coronary Syndrome

The American journal of cardiology, 2008-07, Vol.102 (2), p.135-139

2008

Volltextzugriff (PDF)

Ambulation after femoral sheath removal in percutaneous coronary intervention: a prospective comparison of early vs. late ambulation

Journal of clinical nursing, 2009-07, Vol.18 (13), p.1862-1870

2009

Volltextzugriff (PDF)

Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial

The American heart journal, 2018-09, Vol.203, p.17-24

2018

Volltextzugriff (PDF)

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin

Journal of thrombosis and thrombolysis, 2019-07, Vol.48 (1), p.27-34

2019

Volltextzugriff (PDF)

Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival : Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial

The American heart journal, 2008-06, Vol.155 (6), p.1039-1046

2008

Volltextzugriff (PDF)

Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid

British journal of clinical pharmacology, 2005-12, Vol.60 (6), p.623-628

2005

Volltextzugriff (PDF)

Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: From early reduction in reocclusion to improved long-term clinical outcome

The American heart journal, 2009-03, Vol.157 (3), p.532-540

2009

Volltextzugriff (PDF)

The lady aspirin for cardiovascular disease

The Lancet (British edition), 2005-10, Vol.366 (9492), p.1148-1150

2005

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Reduction of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Rivaroxaban in ATLAS-ACS 2 TIMI 51

Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

High T2-weighted signal intensity is associated with elevated troponin T in hypertrophic cardiomyopathy

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

Who is ineligible for warfarin in atrial fibrillation?

N-terminal pro–brain natriuretic peptide for additional risk stratification in patients with non–ST-elevation acute coronary syndrome and an elevated troponin T: An Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy

An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: The OPTIMA-2 randomized controlled trial

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized With Acute Coronary Syndrome

Ambulation after femoral sheath removal in percutaneous coronary intervention: a prospective comparison of early vs. late ambulation

Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin

Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival : Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial

Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid

Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: From early reduction in reocclusion to improved long-term clinical outcome

The lady aspirin for cardiovascular disease

Aktive Filter

Suchergebnisse filtern